Company Information

Company name Aptahem AB
Business idea Aptahem AB is a biotechnology company whose business concept is to develop aptamer-based drugs for the treatment of acute life-threatening conditions where coagulation and inflammation interact in the disease process. The company also carries out business development work towards future partners and licensees. The company’s main candidate, Apta-1, is developed as an emergency drug designed to prevent the progression of life-threatening organ- and tissue damages in sepsis patients.
CEO Mikael Lindstam
Chairman of the Board Bert Junno
Board of directors Bert Junno Johan Lindh Cristina Glad Theresa Comiskey Olsen Mikael Lindstam
Number of employees 6
Organisation number 556970-5782
Article of association Bolagsordning 2018-11-09
Address Norra Vallgatan 58, 4 tr
Zip code 211 22
City Malmö
Phone 0766 – 33 36 99